Efficacy Analysis Of Ultrasound-guided Percutaneous Catheter Drainage For Severe Acute Pancreatitis

Objective: Based on the clinical data of 271 patients with severe acute pancreatitis admitted to the First Hospital of Jilin University from January 2018 to December 2012,the clinical value of ultrasound-guided percutaneous catheter drainage in the treatment of severe acute pancreatitis was investigated.Methods:A total of 271 patients with severe acute pancreatitis in the First Hospital of Jilin University from January,2018 to December,2020.Among them,157 cases were in the PCD experimental group and 114 cases were in the control group.The therapeutic effect of percutaneous catheter drainage was retrospectively analyzed.The treatment effect of the two groups was divided into recovery,improvement,invalid to surgery,and death.Results:(1)The experimental group included 157 patients,including 75 males and 82 females,aged 18-80 years,with an average age of 44.3 years.There were 114 cases in the control group,including 44 males and 70 females,aged 19-79 years,with an average age of 43.6 years.There was no difference in gender and age distribution between the two groups.The clinical symptoms and signs of the experimental group and the control group were abdominal pain(152 cases vs 110 cases),abdominal distension(104 cases vs 86 case),nausea and vomiting(73 cases vs 61 cases),fever(37 cases vs 22 cases),abdominal tenderness(153 cases vs 110 cases),rebound pain(104 cases vs 99 cases),and shifting dullness(19 cases vs 11 cases),P>0.05,there was no difference in symptoms and signs between the two groups.(2)The experimental group and the control group were divided into effective(including cure + improvement)(142 cases vs 87 cases),invalid(including invalid conversion to operation +death)(15 cases vs 27 cases),P < 0.05.There was difference in the treatment results between the experimental group and the control group.The curative effect of the experimental group was better than that of the control group.PCD could reduce the mortality(5.73% vs 14.03%).(3)The duration of abdominal pain(8.7±2.9 days vs 12.47±3.38 days)and abdominal distension(3.77±1.40 days vs 12.52±2.89 days)in the experimental group and the control group were compared,P < 0.05,the difference was statistically significant.The duration of abdominal pain and abdominal distension in the experimental group could be shortened.(4)Comparison of the incidence of complications(MODS(7.64%vs22.81%),septic shock(10.83%vs20.18%),ACS(3.18%vs8.77%),DIC(0.64%vs1.75))between the experimental group and the control group was statistically significant(P<0.05).PCD can reduce the incidence of SAP complications.(5)In the experimental group,the length of hospital stay was(22.10±7.49 days vs 24.23±6.65 days),hospitalization expenses(47000±32900yuan vs 58900±48800 yuan),P<0.05,The difference was statistically significant.PCD can shorten the length of hospital stay and reduce the cost of hospitalization.Conclusion:(1)PCD is an effective method to treat SAP,and its efficacy is better than that of the conventional treatment group.(2)PCD is beneficial to shorten the duration of abdominal distension and pain symptoms,shorten the course of disease,prevent complications,reduce mortality,and reduce hospitalization costs.